Immunovia AB (publ)
STO:IMMNOV

Watchlist Manager
Immunovia AB (publ) Logo
Immunovia AB (publ)
STO:IMMNOV
Watchlist
Price: 0.227 SEK -2.58% Market Closed
Market Cap: 152.7m SEK

Intrinsic Value

The intrinsic value of one IMMNOV stock under the Base Case scenario is 0.29 SEK. Compared to the current market price of 0.227 SEK, Immunovia AB (publ) is Undervalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IMMNOV Intrinsic Value
0.29 SEK
Undervaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Immunovia AB (publ)

What is Valuation History?
Ask AI Assistant
What other research platforms think about IMMNOV?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is IMMNOV valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Immunovia AB (publ).

Explain Valuation
Compare IMMNOV to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IMMNOV?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Immunovia AB (publ)

Current Assets 33m
Receivables 3.3m
Other Current Assets 29.7m
Non-Current Assets 2m
PP&E 720k
Intangibles 1.5m
Other Non-Current Assets -250k
Current Liabilities 17m
Other Current Liabilities 17m
Efficiency

Free Cash Flow Analysis
Immunovia AB (publ)

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Immunovia AB (publ)

Revenue
785k SEK
Cost of Revenue
-57.6m SEK
Gross Profit
-56.8m SEK
Operating Expenses
-37.4m SEK
Operating Income
-94.1m SEK
Other Expenses
-31.4m SEK
Net Income
-125.5m SEK
Fundamental Scores

IMMNOV Profitability Score
Profitability Due Diligence

Immunovia AB (publ)'s profitability score is 42/100. The higher the profitability score, the more profitable the company is.

42/100
Profitability
Score

Immunovia AB (publ)'s profitability score is 42/100. The higher the profitability score, the more profitable the company is.

IMMNOV Solvency Score
Solvency Due Diligence

Immunovia AB (publ)'s solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
40/100
Solvency
Score

Immunovia AB (publ)'s solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IMMNOV Price Targets Summary
Immunovia AB (publ)

Wall Street analysts forecast IMMNOV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMMNOV is 0.745 SEK with a low forecast of 0.737 SEK and a high forecast of 0.767 SEK.

Lowest
Price Target
0.737 SEK
225% Upside
Average
Price Target
0.745 SEK
228% Upside
Highest
Price Target
0.767 SEK
238% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Immunovia AB (publ)
does not pay dividends
Shareholder Yield

Current shareholder yield for IMMNOV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one IMMNOV stock?

The intrinsic value of one IMMNOV stock under the Base Case scenario is 0.29 SEK.

Is IMMNOV stock undervalued or overvalued?

Compared to the current market price of 0.227 SEK, Immunovia AB (publ) is Undervalued by 22%.

Back to Top